Ebolavirus Disease Withdrawn Phase 2 / 3 Trials for Amiodarone (DB01118)

Also known as: Ebola Virus Disease

IndicationStatusPhase
DBCOND0073542 (Ebolavirus Disease)Withdrawn2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02307591Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola)Treatment